• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Article

You have full text access to this OnlineOpen article

LIF receptor-gp130 interaction investigated by homology modeling: Implications for LIF binding

  1. David K. Smith1,2,†,
  2. Herbert R. Treutlein1,*

Article first published online: 31 DEC 2008

DOI: 10.1002/pro.5560070406

Issue

Protein Science

Protein Science

Volume 7, Issue 4, pages 886–896, April 1998

Additional Information

How to Cite

Smith, D. K. and Treutlein, H. R. (1998), LIF receptor-gp130 interaction investigated by homology modeling: Implications for LIF binding. Protein Science, 7: 886–896. doi: 10.1002/pro.5560070406

Author Information

  1. 1

    Molecular Modelling Group, Ludwig Institute for Cancer Research, and Cooperative Research Centre for Cellular Growth Factors, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia

  2. 2

    Biochemistry Department, University of Melbourne, Parkville, Victoria, 3052, Australia

  1. †

    Biochemistry Department, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong

*Molecular Modelling Group, Ludwig Institute for Cancer Research, PO Box 2008, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia

Publication History

  1. Issue published online: 31 DEC 2008
  2. Article first published online: 31 DEC 2008
  3. Manuscript Accepted: 20 DEC 1997
  4. Manuscript Received: 23 JUL 1997

Funded by

  • University of Melbourne special scholarship
  • Victorian Education Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (7632K)

References

  • Banner DW, D'arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. 1996. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380: 41–46.
  • Bazan JF. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934–6938.
  • Bazan JF. 1991. Neuropoietic cytokines in the hematopoietic fold. Neuron 7: 197–208.
  • Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr., Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. 1977. The Protein Data Bank: A computer-based archival file for macromolecular structures. J Mol Biol 112: 535–542.
  • Bowie JU, Lüthy R, Eisenberg D. 1991. A method to identify protein sequences that fold into a known three-dimensional structure. Science 253: 164–170.
  • Brünger AT. 1992. X-PLOR, a system for crystallography and NMR. New Haven. Connecticut: Yale University.
  • Cheema SS, Richards L, Murphy M, Bartlett PF. 1994. Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat. J Neurosci Res 37: 213–218.
    Direct Link:
  • Chua AO, Chizzonite R, Desai BB, Truitt TP. Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, Gubler U. 1994. Expression cloning of a human IL-12 receptor component. J Immunol 153: 128–136.
  • Clackson T, Wells JA. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267: 383–386.
  • Cornelis S, Plaetinck G, Devos R, Van der Heyden J, Tavernier J, Sanderson CJ, Guisez Y, Fiers W. 1995. Detailed analysis of the IL-5-IL-5R interaction: Characterization of crucial residues on the ligand and the receptor. EMBO J 14: 3395–3402.
  • Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. 1995. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117: 5179–5197.
  • Cosman D. 1993. The hematopoietin receptor superfamily. Cytokin 5: 95–106.
  • Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254821-825
  • Cunningham BC, Wells JA. 1993. Comparison of a structural and a functional epitope. J Mol Biol 234: 554–563.
  • Demchuk E, Mueller T, Oschkinat H, Sebald W, Wade RC. 1994. Receptor binding properties of four-helix-bundle growth factors deduced from electrostatic analysis. Protein Sci 3: 920–935.
    Direct Link:
  • de Serio A, Graziani R, Laufer R, Ciliberto G, Paonessa G. 1995. In vitro binding of ciliary neurotrophic factor to its receptors: Evidence for the formation of an IL-6-type hexameric complex. J Mol Biol 254: 795–800.
  • de Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255: 306–312.
  • Dickinson CD, Veerapandian B, Dai XP, Hamlin RC, Xuong N, Ruoslahti E, Ely KR. 1994. Crystal structure of the tenth type III cell adhesion module of human fibronectin. J Mol Biol 236: 1079–1092.
  • di Marco A, Gloaguen I, Graziani R, Paonessa G. Saggio I, Hudson KR, Laufer R. 1996. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF antagonists. Proc Natl Acad Sci USA 95: 9247–9252.
  • Fukunaga R, Ishizaka-Ikeda E, Pan CX, Seto Y, Nagata S. 1991. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 10: 2855–2865.
  • Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D. 1992. The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434–1437.
  • Gearing DP, Thut CJ, van den Bos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10: 2839–2848.
  • Gilson MK, Sharp KA, Honig BH. 1988. Calculating the electrostatic potential of molecules in solution: Method and error assessment. J Comp Chem 9: 327–335.
    Direct Link:
  • Graber P, Proudfoot AEI, Talabot F, Bernard A, McKinnon M, Banks M, Fattah D, Solari R, Peitsch MC, Wells TNC. 1995. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation. J Biol Chem 270: 15762–15769.
  • Harlos K, Martin DMA, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EGD, Boys CWG. 1994. Crystal structure of the extracellular region of human tissue factor. Nature 370: 662–666.
  • Hemmingsen JM, Gernert KM, Richardson JS, Richardson DC. 1994. The tyrosine corner: A feature of most Greek key β-barrel proteins. Protein Sci 3: 1927–1937.
    Direct Link:
  • Hendlich M, Lackner P, Weitckus S, Floeckner H, Froschauer R, Gottsbacher K, Casari G, Sippl MJ. 1990. Identification of native protein folds amongst a large number of incorrect models. J Mol Biol 213: 859–883.
  • Hilton DJ. 1992. LIF: Lots of interesting functions. Trends Biochem Sci 17: 72–76.
  • Hiraoka O, Anaguchi H, Asakura A, Ota Y. 1995. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor information of a 2:1 receptor-ligand complex. J Biol Chem 270: 25928–25934.
  • Huber AH, Eureka Wang Y, Bieber AJ, Bjorkman PJ. 1994. Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 Å. Neuron 12: 717–731.
  • Hudson KR, Vernallis AB, Heath JK. 1996. Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of agonists. J Biol Chem 271: 11971–11978.
  • Jenkins BJ, D'Andrea R, Gonda TJ. 1995. Activating point mutations in the common subunit of the human GM-CSF, IL-3 and 1L-5 receptors suggest the involvement of subunit dimerization and cell type-specific molecules and signalling. EMBO J 17: 4276–4287.
  • Jorgensen WL, Tirado-Rives J. 1988. The OPLS potential functions for proteins. Energy minimisations for crystals of cyclic peptides and crambin. J Am Chem Soc 110: 1657–1666.
  • Kabsch W, Sander C. 1983. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometric features. Biopolymers 22: 2577–2637.
    Direct Link:
  • Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86: 1243–1254.
  • Kraulis P. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24: 946–950.
    Direct Link:
  • Kruse N, Shen BJ, Arnold S, Tony HP, Muller T, Sebald W. 1993. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J 12: 5121–5129.
  • Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr 26: 283–291.
    Direct Link:
  • Layton JE, Laria J, Smith DK, Treutlein HR. 1997. Identification of a ligand binding site on the granulocyte colony-stimulating factor receptor by molecular modeling and mutagenesis. J Biol Chem 272: 29735–29741.
  • Layton MJ, Lock P, Metcalf D, Nicola NA. 1994a. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. J Biol Chem 269: 17048–17055.
  • Layton MJ, Owczarek CM, Metcalf D, Clark RL, Smith DK, Treutlein HR, Nicola NA. 1994b. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. J Biol Chem 269: 29891–29896.
  • Leahy DJ, Hendrickson WA, Aukhil I, Erickson HP. 1992. Structure of a fibronectin type III domain from Tenascin phased by MAD analysis of the selenomethionyl protein. Science 258: 987–991.
  • Li M, Sendtner M, Smith A. 1995. Essential function of LIF receptor in motorneurons. Nature 378: 124–727.
  • Livnah O, Stura EA, Johnson DL, Middleon SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA. 1996. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8. Science 273: 464–471.
  • Lopez AF, Shannon MF, Hercus T, Nicola NA, Cambareri B, Dottore M, Layton MJ, Eglinton L, Vadas MA. 1992. Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO J 11: 909–916.
  • Lüthy R, Bowie JU, Eisenberg D. 1992. Assessment of protein models with three-dimensional profiles. Nature 356: 83–85.
  • McDonald NQ, Panayolatos N, Hendrickson WA. 1995. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAO phasing. EMBO J 14: 2689–2699.
  • Melcalf D. 1992. Leukemia inhibitory factor—A puzzling polyfunctional regulator. Growth Factors 7: 169–173.
  • Mosley B, de Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D. 1996. Dual Oncostatin M (OSM) receptors. Cloning and characterization of an alternative signalling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635–32643.
  • Mott HR, Campbell ID. 1995. Four-helix bundle growth factors and their receptors: Protein-protein interactions. Curr Opin Struct Biol 5: 114–121.
  • Muller YA, Ultsch MH, de Vos AM. 1996. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 Å resolution. J Mol Biol 256: 144–159.
  • Muller YA, Ultsch MH, Kelley RF, de Vos AM. 1994. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry 33: 10864–10870.
  • Nicholls A, Honig B. 1991. A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation. J Comp Chem 12: 435–445.
    Direct Link:
  • Nicholls A, Sharp KA, Honig BH. 1991. Protein folding and associations: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct Fund Genet 11: 281–296.
    Direct Link:
  • Olins PO, Bauer SC, Bradford-Goldberg S, Sterbcnz K, Polazzi JO, Caparon MH, Klein BK, Easton AM, Paik K, Klover JA, Thiele BR, McKearn JP. 1995. Saturation mutagenesis of human lnterleukin-3. J Biol Chem 270: 23754–23760.
  • Owczarek CM, Layton MJ, Metcalf D, Lock P, Willson TA. Gough NM. Nicola NA. 1993. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant. EMBO J 12: 3487–3495.
  • Owczarek CM, Zhang Y, Layton MJ, Metcalf D, Roberts B, Nicola NA. 1997. The unusual species cross-reactivity of the leukemia inhibitory factor receptor α-chain is determined primarily by the immunoglobulin-like domain. J Biol Chem 272: 23976–23985.
  • Paonessa G, Graziani R, de Serio A, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, Ciliberto G. 1995. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J 9: 1942–1951.
  • Patterson PH. 1994. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc Natl Acad Sci USA 91: 7833–7835.
  • Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P, Landis SC. 1993. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11: 1175–1185.
  • Robinson RC, Grey LM, Staunton D, Vankelecom H, Vernallis AB, Moreau JF, Stuart DI, Heath JK, Jones EY. 1994. The crystal structure and biological function of Leukemia Inhibitory Factor: Implications for receptor binding. Cell 77: 1101–1116.
  • Robledo O, Auguste P, Coupey L, Praloran V, Chevalier S, Pouplard A, Gascan H. 1996. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors. J Neurochem 66: 1391–1399.
    Direct Link:
  • Seto MH, Harkins RN, Adler M, Whitlow M, Church WB, Croze E. 1995. Homology model of human interferon-8 and its receptor complex. Protein Sci 4: 655–670.
    Direct Link:
  • Simpson RJ, Hammacher A, Smith DK, Matthews JM, Ward LD. 1997. Interleukin-6: Structure-function relationships. Protein Sci 6: 929–955.
    Direct Link:
  • Sippl MJ. 1993. Recognition of errors in three-dimensional structures of proteins. Proteins Struct Funct Genet 17: 355–362.
    Direct Link:
  • Smith DK. 1996. Structural studies of leukaemia inhibitory factor (LIF) and its receptors [thesis]. Melbourne. Australia: University of Melbourne.
  • Smith DK, Treutlein HR, Maurer T, Owczarek CM, Layton MJ, Nicola NA, Norton RS. 1994. Homology modelling and 1H NMR studies of human leukaemia inhibitory factor. FEBS Lett 350: 275–280.
  • Somers W, Ultsch M, de Vos AM, Kossiakoff AA. 1994. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372: 478–481.
  • Sprang SR, Bazan JF. 1993. Cytokine structural taxonomy and mechanisms of receptor engagement. Curr Opin Struct Biol 3: 815–827.
  • Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 379: 76–79.
  • Sundström M, Lundqvist T, Rödin J, Giehel LB, Milligan D, Norstedt G. 1996. Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 resolution. J Biol Chem 271: 32197–32203.
  • Tham S, Dowsing B, Finklestein D, Donato R, Surinda SS, Bartletl PF, Morrison WA. 1997. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 47: 208–215.
    Direct Link:
  • Walter MR, Windsor WT, Nagabhushan TL, Lundell DJ, Lunn CA, Zauodny PJ, Narula SK. 1995. Crystal structure of a complex between interferon- and its soluble high-affinity receptor. Nature 376: 230–235.
  • Ware CB, Horowitz MC, Renshaw BR. Hunt JS, Liggit D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Barllett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP. 1995. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121: 1283–1299.
  • Wells JA. 1996. Binding in the growth hormone receptor complex. Proc Natl Acad Sci USA 93: 1–6.
  • Wells JA, de Vos AM. 1996. Hematopoietic receptor complexes. Annu Rev Biochem 65: 609–634.
  • Woodcock JM, Bagley CJ, Zacharakis B, Lopez AF. 1996. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common β-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J Biol Chem 271: 25999–26006.
  • Yawata H, Yasukawa K, Shunji N, Murakami M, Yamasaki K, Hibi M, Taga T, Kishimoto T. 1993. Structure-function analysis of human IL-6 receptor: Dissociation of amino acid residues required for IL-6 binding and for IL-6 signal transduction through gp130. EMBO J 12: 1705–1712.
  • Zhang JG, Owczarek CM, Ward LD, Howlett GJ, Fabri LJ, Roberts BA, Nicola NA. 1997. Evidence for the formation of a helerotrimcric complex of leukaemia inhibitory factor with its receptor subunits in solution. Biochem J 325: 693–700.
  • Zurawski SM, Vega F, Doyle EL, Huyghe B, Flaherty K, Mckay DB, Zurawski G. 1993. Definition and spatial location of mouse interleukin-2 residues that interact with its heteromeric receptor. EMBO J 12: 5113–5119.
Get PDF (7632K)